ULCERATIVE COLITIS

This study looked at the long-term safety and effectiveness of the drug vedolizumab (Entyvio) in over 1,100 people with moderate to severe ulcerative colitis. Participants had not responded well to other treatments. The goal was to see how well the drug works and what side effect…

This study looked at whether measuring the amount of anti-TNF medication and antibodies in the blood can help doctors make better treatment decisions for people with Crohn's disease or ulcerative colitis. About 260 patients were split into two groups: one where doctors used these…

This study looked at whether a short-term, plant-based low-calorie diet (called a fasting mimicking diet) could improve depressive symptoms in people with inflammatory bowel disease (IBD). 42 adults with IBD and mild-to-moderate depression completed three 5-day diet cycles. Resea…

This study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who were already using a standard adalimumab injection. They switched to a higher-concentration version (AVT-02) to see if it caused less pain at the injection site and if patients stuck …

This study examined infection rates in nearly 24,000 older adults (65+) with ulcerative colitis or Crohn's disease who started treatment with ENTYVIO, TNF-alpha inhibitors, or ustekinumab. Using Medicare claims data from 2016 to 2025, researchers compared how many people had seri…

This study watched 165 people with inflammatory bowel disease (Crohn's or colitis) in Poland as they started or continued vedolizumab treatment. Researchers did not give any treatment – they simply recorded whether patients chose intravenous (IV) or at-home injections, and tracke…